Zydus Lifesciences revenue rises 22% in Q1 FY27
Q1 FY27 Highlights
Revenue from operations at Rs. 80,170 mn, up 22% over last year.
R&D investments for the quarter stood at Rs. 6,424 mn (8% of revenues).
EBITDA for the quarter was Rs. 19,294 mn, down 8% y-o-y. EBITDA margin!-->!-->!-->!-->!-->!-->!-->…
Read More...
Read More...